PortfoliosLab logo
CORT vs. BOOT
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Correlation

The correlation between CORT and BOOT is 0.35, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.


Performance

CORT vs. BOOT - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Corcept Therapeutics Incorporated (CORT) and Boot Barn Holdings, Inc. (BOOT). The values are adjusted to include any dividend payments, if applicable.

500.00%1,000.00%1,500.00%2,000.00%2,500.00%3,000.00%December2025FebruaryMarchAprilMay
1,963.01%
581.03%
CORT
BOOT

Key characteristics

Sharpe Ratio

CORT:

1.50

BOOT:

0.28

Sortino Ratio

CORT:

4.18

BOOT:

0.69

Omega Ratio

CORT:

1.57

BOOT:

1.10

Calmar Ratio

CORT:

4.35

BOOT:

0.27

Martin Ratio

CORT:

12.52

BOOT:

0.66

Ulcer Index

CORT:

15.79%

BOOT:

20.38%

Daily Std Dev

CORT:

122.13%

BOOT:

53.62%

Max Drawdown

CORT:

-94.28%

BOOT:

-83.73%

Current Drawdown

CORT:

-37.51%

BOOT:

-31.90%

Fundamentals

Market Cap

CORT:

$7.72B

BOOT:

$3.44B

EPS

CORT:

$1.23

BOOT:

$5.60

PE Ratio

CORT:

59.16

BOOT:

20.06

PEG Ratio

CORT:

0.61

BOOT:

1.72

PS Ratio

CORT:

11.62

BOOT:

1.86

PB Ratio

CORT:

11.36

BOOT:

3.18

Total Revenue (TTM)

CORT:

$685.45M

BOOT:

$1.46B

Gross Profit (TTM)

CORT:

$674.70M

BOOT:

$548.46M

EBITDA (TTM)

CORT:

$111.33M

BOOT:

$237.14M

Returns By Period

In the year-to-date period, CORT achieves a 41.66% return, which is significantly higher than BOOT's -21.72% return. Over the past 10 years, CORT has outperformed BOOT with an annualized return of 28.81%, while BOOT has yielded a comparatively lower 17.36% annualized return.


CORT

YTD

41.66%

1M

1.26%

6M

31.45%

1Y

181.02%

5Y*

39.82%

10Y*

28.81%

BOOT

YTD

-21.72%

1M

29.29%

6M

-11.62%

1Y

14.71%

5Y*

43.37%

10Y*

17.36%

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

CORT vs. BOOT — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

CORT
The Risk-Adjusted Performance Rank of CORT is 9696
Overall Rank
The Sharpe Ratio Rank of CORT is 9191
Sharpe Ratio Rank
The Sortino Ratio Rank of CORT is 9898
Sortino Ratio Rank
The Omega Ratio Rank of CORT is 9797
Omega Ratio Rank
The Calmar Ratio Rank of CORT is 9999
Calmar Ratio Rank
The Martin Ratio Rank of CORT is 9696
Martin Ratio Rank

BOOT
The Risk-Adjusted Performance Rank of BOOT is 6161
Overall Rank
The Sharpe Ratio Rank of BOOT is 6363
Sharpe Ratio Rank
The Sortino Ratio Rank of BOOT is 5858
Sortino Ratio Rank
The Omega Ratio Rank of BOOT is 5858
Omega Ratio Rank
The Calmar Ratio Rank of BOOT is 6565
Calmar Ratio Rank
The Martin Ratio Rank of BOOT is 6060
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

CORT vs. BOOT - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Corcept Therapeutics Incorporated (CORT) and Boot Barn Holdings, Inc. (BOOT). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


The current CORT Sharpe Ratio is 1.50, which is higher than the BOOT Sharpe Ratio of 0.28. The chart below compares the historical Sharpe Ratios of CORT and BOOT, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio0.001.002.003.004.005.00December2025FebruaryMarchAprilMay
1.50
0.28
CORT
BOOT

Dividends

CORT vs. BOOT - Dividend Comparison

Neither CORT nor BOOT has paid dividends to shareholders.


Tickers have no history of dividend payments

Drawdowns

CORT vs. BOOT - Drawdown Comparison

The maximum CORT drawdown since its inception was -94.28%, which is greater than BOOT's maximum drawdown of -83.73%. Use the drawdown chart below to compare losses from any high point for CORT and BOOT. For additional features, visit the drawdowns tool.


-50.00%-40.00%-30.00%-20.00%-10.00%0.00%December2025FebruaryMarchAprilMay
-37.51%
-31.90%
CORT
BOOT

Volatility

CORT vs. BOOT - Volatility Comparison

The current volatility for Corcept Therapeutics Incorporated (CORT) is 16.59%, while Boot Barn Holdings, Inc. (BOOT) has a volatility of 18.65%. This indicates that CORT experiences smaller price fluctuations and is considered to be less risky than BOOT based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


0.00%20.00%40.00%60.00%80.00%December2025FebruaryMarchAprilMay
16.59%
18.65%
CORT
BOOT

Financials

CORT vs. BOOT - Financials Comparison

This section allows you to compare key financial metrics between Corcept Therapeutics Incorporated and Boot Barn Holdings, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


100.00M200.00M300.00M400.00M500.00M600.00M20212022202320242025
157.21M
608.17M
(CORT) Total Revenue
(BOOT) Total Revenue
Values in USD except per share items

CORT vs. BOOT - Profitability Comparison

The chart below illustrates the profitability comparison between Corcept Therapeutics Incorporated and Boot Barn Holdings, Inc. over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

Gross Margin
Operating Margin
Net Margin
Quarterly
Annual

20.0%40.0%60.0%80.0%100.0%20212022202320242025
98.5%
39.3%
(CORT) Gross Margin
(BOOT) Gross Margin
CORT - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, Corcept Therapeutics Incorporated reported a gross profit of 154.81M and revenue of 157.21M. Therefore, the gross margin over that period was 98.5%.

BOOT - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, Boot Barn Holdings, Inc. reported a gross profit of 238.87M and revenue of 608.17M. Therefore, the gross margin over that period was 39.3%.

CORT - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, Corcept Therapeutics Incorporated reported an operating income of 3.42M and revenue of 157.21M, resulting in an operating margin of 2.2%.

BOOT - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, Boot Barn Holdings, Inc. reported an operating income of 99.46M and revenue of 608.17M, resulting in an operating margin of 16.4%.

CORT - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, Corcept Therapeutics Incorporated reported a net income of 20.29M and revenue of 157.21M, resulting in a net margin of 12.9%.

BOOT - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, Boot Barn Holdings, Inc. reported a net income of 75.07M and revenue of 608.17M, resulting in a net margin of 12.3%.